Health Care·Pharmaceuticals·$49.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.43 | N/A | +11.40% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.43 | N/A | +11.40% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management expressed confidence in the company's market position despite not providing specific guidance. They emphasized their commitment to innovation.
Management highlighted strong demand for animal health products.
They noted ongoing investments in innovation to drive future growth.
Zoetis Inc's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reaction was flat, suggesting that investors may have already priced in these results. The lack of revenue data and guidance could lead to uncertainty in future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
RESTAURANT BRANDS IN
Feb 16, 2016